Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Merck to develop personalized cancer vaccine in collaboration with Moderna

Ruchika Sharma13 Oct 2022 12:15 PM IST

Under the agreement, originally established in 2016 and amended in 2018, Merck will pay Moderna $250 million to exercise its option for personalized...

VINS Bioproducts completes Phase 2 clinical trials of COVID antidote VINCOV-19

Ruchika Sharma13 Oct 2022 11:15 AM IST

Hyderabad: VINS Bioproducts Limited, an immunological company, based in Hyderabad, in collaboration with the Centre for Cellular and...

India halts production of cough syrup at Maiden Pharma factory

Ruchika Sharma12 Oct 2022 3:30 PM IST

The cough syrups had been approved for export only to Gambia, India says, although the WHO says they may have gone elsewhere through informal markets.

Amneal Pharma-mAbxience gets USFDA approval for Boncresa, Oziltus

Amneal Pharma starts commercial operations in India

Ruchika Sharma12 Oct 2022 2:30 PM IST

Mumbai: Amneal Pharmaceuticals, Inc., has announced the launch of its commercial operations in India. To helm its India Commercial operations, Amneal...

Biocon CSR arm conferred with Mahatma Award 2022 For Excellence in Social Good

Ruchika Sharma12 Oct 2022 1:30 PM IST

Biocon Foundation has received the award under the ‘Sustainable Cities and Communities’ category for the work done by the Foundation in Bengaluru...

Dr Reddys Foils Email Spoofing Scam, Rs 2.16 Cr Recovered by Bengaluru Police

Dr Reddy's Labs, Cipla facilities join World Economic Forum Global Lighthouse Network

Ruchika Sharma12 Oct 2022 12:08 PM IST

On Cipla, the WEF said the company deployed digital, automation and analytics solutions to 22 Indian sites to preserve access to high-quality...

Sanofi to buy Vigil Neuroscience in USD 470 million deal

Marksans Pharma plans to double manufacturing capacity with acquisition of Tevapharm India bulk formulations business

Ruchika Sharma12 Oct 2022 11:15 AM IST

Marksans plans to manufacture tablets, hard and soft gel capsules, ointments, gummies, and creams, from the new capacity.

AstraZeneca gets USFDA approval for perioperative Imfinzi for bladder cancer

Setback: AstraZeneca nasal spray COVID vaccine fails in early trial

Ruchika Sharma11 Oct 2022 3:33 PM IST

The immune response measured in the blood was weaker than that from a shot-in-the-arm vaccination.

Alert does not reflect current situation: Indian Immunologicals on fake Abhayrab claims

Indian Immunologicals to infuse Rs 700 crore to set up animal vaccine facility in Genome Valley

Ruchika Sharma11 Oct 2022 2:30 PM IST

IL's intended new facility, in Genome Valley Phase 3, will add another 300 million doses/annum of FMD vaccine to its capacity.

Gujarat: PM Modi lays foundation stone of Bulk Drug Park at Jambusar

Ruchika Sharma11 Oct 2022 1:30 PM IST

"Gujarat helped the country a great deal in the war against coronavirus. Gujarat accounts for 25 percent share of the country's pharma export," PM...

Bal Krishan Saini designated as Senior Management Personnel of Panacea Biotec Pharma

Panacea Biotec gets UNICEF, PAHO awards for supply of liquid Pentavalent vaccine Easyfive-n

Ruchika Sharma11 Oct 2022 12:28 PM IST

EasyFive-n is a ready-to-use combination vaccine that does not require preparation by healthcare workers at the clinic, reduces the number of visits...

Anti-trust regulator CCI clears Abu Dhabi Investment Authority minority stake acquisition in Intas Pharma

Ruchika Sharma11 Oct 2022 11:15 AM IST

New Delhi: Anti-trust regulator Competition Commission of India (CCI) has cleared Platinum Owl's acquisition of a minority stake in Intas...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok